Best Biotechnology Stocks

Compare the best biotech stocks to buy today.

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	PE Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$179.20 +0.5%	62.22	$316.67 billion	783,788	5.59 million
TMO Thermo Fisher Scientific	$526.38 +0.2%	33.00	$201.34 billion	128,664	1.55 million	Analyst Forecast
DHR Danaher	$230.05 +0.4%	43.90	$166.16 billion	245,017	2.82 million	Analyst Forecast
VRTX Vertex Pharmaceuticals	$408.26 +0.7%	N/A	$105.14 billion	276,840	1.24 million	Analyst Forecast Analyst Revision
GSK GSK	$34.16 +0.3%	22.18	$70.80 billion	485,897	4.15 million
COR Cencora	$228.34 +0.3%	30.40	$44.13 billion	68,523	1.38 million	Insider Trade
A.I. Trading System Helps Some Traders Pocket $1,100 per DAY! (Ad) What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a day Click HERE to access this powerful AI Trading System
TAK Takeda Pharmaceutical	$13.12 -0.4%	22.62	$41.75 billion	139,471	1.82 million	Positive News
CTSH Cognizant Technology Solutions	$79.27 +0.3%	17.54	$39.30 billion	148,400	3.73 million
ARGX argenx	$629.68 +0.2%	N/A	$38.01 billion	3,792	306,782	Positive News
IQV IQVIA	$199.73 +0.3%	26.21	$36.25 billion	118,964	1.20 million
VEEV Veeva Systems	$216.37 -3.8%	53.42	$35.13 billion	474,864	990,934
ALNY Alnylam Pharmaceuticals	$241.30 -0.4%	N/A	$31.12 billion	78,736	857,605
BNTX BioNTech	$113.20 -0.3%	N/A	$26.91 billion	17,326	805,015
ILMN Illumina	$135.86 +0.6%	N/A	$21.55 billion	69,326	2.05 million
LH Laboratory Co. of America	$228.44 +0.3%	44.19	$19.11 billion	30,908	656,433
ICLR ICON Public	$211.88 +0.9%	23.62	$17.48 billion	68,193	759,447
UTHR United Therapeutics	$363.90 +0.1%	15.98	$16.25 billion	9,946	446,434
MRNA Moderna	$39.18 -1.0%	N/A	$15.08 billion	885,266	5.13 million
RPRX Royalty Pharma	$25.30 +0.2%	13.11	$14.91 billion	353,886	2.69 million	Positive News
RVTY Revvity	$112.23 0.0%	54.22	$13.66 billion	38,768	845,051
SUZ Suzano	$10.02 +1.0%	15.91	$13.27 billion	124,044	1.83 million
PCVX Vaxcyte	$86.06 -1.2%	N/A	$10.73 billion	40,013	919,625
MEDP Medpace	$340.90 +0.5%	29.85	$10.60 billion	22,200	282,793
CRL Charles River Laboratories International	$186.28 +0.5%	23.31	$9.53 billion	69,004	616,589
BIO.B Bio-Rad Laboratories	$325.85	N/A	$9.12 billion	8	874
FN Fabrinet	$222.53 +0.7%	26.33	$8.07 billion	45,648	496,466	Positive News
IBB iShares Biotechnology ETF	$133.71 +0.1%	N/A	$6.75 billion	170,040	1.46 million
LEGN Legend Biotech	$32.56 -4.0%	N/A	$5.95 billion	342,284	1.14 million
LITE Lumentum	$83.94 +0.9%	N/A	$5.77 billion	202,822	1.50 million
BE Bloom Energy	$24.04 -0.7%	N/A	$5.49 billion	601,872	6.55 million
TGTX TG Therapeutics	$32.25 0.0%	N/A	$5.02 billion	173,981	3.56 million	Analyst Downgrade
KRYS Krystal Biotech	$159.68 -0.7%	90.22	$4.59 billion	40,990	323,888
HTGC Hercules Capital	$19.51 +0.9%	9.66	$3.17 billion	93,595	945,167
DNLI Denali Therapeutics	$20.91 +0.6%	N/A	$3.01 billion	70,146	1.06 million
FOLD Amicus Therapeutics	$9.70 -1.4%	N/A	$2.90 billion	280,142	2.71 million
TWST Twist Bioscience	$48.21 +0.2%	N/A	$2.86 billion	44,492	941,762
SWTX SpringWorks Therapeutics	$37.33 -0.1%	N/A	$2.78 billion	84,966	1.00 million
VERA Vera Therapeutics	$41.98 -0.8%	N/A	$2.66 billion	26,433	870,502	Positive News
ODD Oddity Tech	$43.98 -1.3%	26.82	$2.50 billion	48,435	645,931	Gap Up
DYN Dyne Therapeutics	$23.98 +0.3%	N/A	$2.44 billion	30,393	1.43 million	Positive News
A.I. Trading System Helps Some Traders Pocket $1,100 per DAY! (Ad) What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a day Click HERE to access this powerful AI Trading System
BEAM Beam Therapeutics	$28.80 +0.3%	N/A	$2.38 billion	92,321	1.23 million
AZTA Azenta	$50.47 +0.9%	N/A	$2.31 billion	53,408	572,584
SXI Standex International	$189.93 +0.5%	31.14	$2.29 billion	5,118	55,768	News Coverage Positive News
IOVA Iovance Biotherapeutics	$7.37 -1.2%	N/A	$2.25 billion	1.07 million	7.17 million
APGE Apogee Therapeutics	$46.91 -1.2%	N/A	$2.11 billion	32,063	501,056
WVE Wave Life Sciences	$13.36 +1.8%	N/A	$2.04 billion	93,355	1.11 million	News Coverage
RXRX Recursion Pharmaceuticals	$7.09 +1.4%	N/A	$2.03 billion	7.32 million	6.79 million	Options Volume Gap Up
IBRX ImmunityBio	$2.66 -0.4%	N/A	$1.85 billion	650,795	5.04 million
GLPG Galapagos	$27.20 +0.4%	N/A	$1.79 billion	18,498	152,278
EVO Evotec	$5.05 +13.2%	N/A	$1.79 billion	89,877	139,212	Positive News
TXG 10x Genomics	$14.73	N/A	$1.78 billion	153,330	1.75 million	News Coverage
FTRE Fortrea	$18.70 -0.4%	N/A	$1.68 billion	42,766	1.29 million
BCRX BioCryst Pharmaceuticals	$7.79 +0.1%	N/A	$1.61 billion	223,343	2.84 million
VRDN Viridian Therapeutics	$19.06 -3.1%	N/A	$1.51 billion	125,631	1.17 million
PHR Phreesia	$25.03 -1.4%	N/A	$1.45 billion	17,478	450,265
IMCR Immunocore	$28.00 -0.5%	N/A	$1.40 billion	36,463	497,217
NVAX Novavax	$8.55 -1.0%	N/A	$1.37 billion	449,424	9.15 million
TPC Tutor Perini	$24.21 -3.3%	N/A	$1.27 billion	89,616	446,197
ARVN Arvinas	$18.25 +1.4%	N/A	$1.25 billion	151,800	735,974
OCSL Oaktree Specialty Lending	$15.18 +1.3%	21.08	$1.25 billion	180,764	693,403
SYRE Spyre Therapeutics	$23.04 -2.3%	N/A	$1.18 billion	89,592	527,442
SEPN Septerna	$26.56 -2.0%	N/A	$1.18 billion	41,156	337,975	News Coverage
RCKT Rocket Pharmaceuticals	$11.57 +1.2%	N/A	$1.05 billion	134,063	841,658
VIR Vir Biotechnology	$7.33 -0.1%	N/A	$1.01 billion	98,399	1.08 million
UPB Upstream Bio	$18.61 +3.8%	N/A	$997.44 million	40,902	360,935
TRNS Transcat	$106.68 +1.4%	53.88	$981.35 million	5,005	55,117	News Coverage
RDW Redwire	$14.60 +3.8%	N/A	$971.50 million	255,935	401,140
THR Thermon Group	$28.78 +0.6%	22.48	$969.45 million	6,953	194,819
ZYME Zymeworks	$14.05 -1.6%	N/A	$967.74 million	56,618	611,036
ADPT Adaptive Biotechnologies	$6.33 +0.2%	N/A	$934.18 million	71,138	1.40 million
SLRC SLR Investment	$16.24 +0.6%	9.18	$885.97 million	70,004	160,179
COGT Cogent Biosciences	$7.74 -0.3%	N/A	$854.98 million	268,252	1.46 million
REPL Replimune Group	$12.47 +1.1%	N/A	$853.16 million	70,087	1.05 million	Gap Up
HQH Abrdn Healthcare Investors	$16.52 +1.1%	N/A	$836.33 million	94,422	167,433	News Coverage Positive News
PRTA Prothena	$15.39 +0.4%	N/A	$828.12 million	62,789	590,021
JTEK JPMorgan U.S. Tech Leaders ETF	$78.63 +1.0%	47.95	$800.45 million	16,424	76,989
CDMO Avid Bioservices	$12.28 +0.1%	N/A	$785.47 million	96,410	1.31 million
TCPC BlackRock TCP Capital	$8.68 +1.6%	N/A	$742.93 million	118,446	512,239
WNC Wabash National	$17.03 +1.1%	N/A	$738.03 million	40,952	582,009	Positive News
TYRA Tyra Biosciences	$14.20 -0.4%	N/A	$718.56 million	17,080	195,619
LAB Standard BioTools	$1.85 -1.1%	N/A	$688.68 million	101,182	2.39 million
DNTH Dianthus Therapeutics	$23.10 -0.3%	N/A	$683.69 million	51,637	204,851	Positive News
IMNM Immunome	$10.91 -0.5%	N/A	$680.97 million	91,633	782,043	Positive News
CRGX CARGO Therapeutics	$14.37 -2.4%	N/A	$661.42 million	26,663	258,979
TRDA Entrada Therapeutics	$17.63 +1.0%	11.09	$659.72 million	11,311	108,378
RAPP Rapport Therapeutics	$18.03	N/A	$659.47 million	7,905	153,994
GRAL Grail	$18.56 -0.9%	N/A	$623.64 million	58,567	1.09 million
CAPR Capricor Therapeutics	$13.69 -3.1%	N/A	$622.48 million	79,497	1.20 million	Positive News
SLP Simulations Plus	$28.25 -0.3%	57.65	$566.89 million	10,308	142,842
DNA Ginkgo Bioworks	$9.39 -0.7%	N/A	$539.73 million	174,642	1.17 million
A.I. Trading System Helps Some Traders Pocket $1,100 per DAY! (Ad) What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a day Click HERE to access this powerful AI Trading System
PROK ProKidney	$1.81 +6.8%	N/A	$526.45 million	167,517	685,719	Gap Up
TRML Tourmaline Bio	$20.47 -3.9%	N/A	$524.91 million	32,291	290,711	Positive News
TKNO Alpha Teknova	$9.47 +23.3%	N/A	$504.83 million	270,853	229,118	Gap Up
OABI OmniAb	$3.49	N/A	$492.84 million	35,468	502,249
RNAC Cartesian Therapeutics	$19.00 -1.8%	N/A	$482.89 million	16,642	100,672
DDD 3D Systems	$3.56 +6.0%	N/A	$482.81 million	716,154	2.34 million
PRTC PureTech Health	$19.92 -1.8%	N/A	$476.93 million	1,573	4,311
CELC Celcuity	$12.49 +0.7%	N/A	$463.75 million	28,965	280,556
ABVX ABIVAX Société Anonyme	$7.32 -0.4%	N/A	$463.71 million	31,762	96,957
ANAB AnaptysBio	$14.39 +3.0%	N/A	$437.87 million	35,114	388,652

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

(Ad)

What if I told you 60 seconds a day could completely change your life?

This AI-powered trading system finds high-probability option trades in less than 60 seconds a day

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools